| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  HepatoChem Reinventing Chemistry for Life Sciences HepatoChem is an emerging life sciences company dedicated to the commercialization of our unique approach for producing new chemical entities for metabolism study and drug discovery. Metabolite synthesis, Custom synthesis, photochemistry, research instrument, and photoreactor Type: | 0 | 0 | 0 | 8 |
 | Butler Scientifics #10YearsExploringData with AutoDiscovery, an intelligent automated exploratory data analysis software. Butler Scientifics developes AutoDiscovery, an automated smart exploratory data analysis software that helps biomedical researchers at unveiling clinically relevant associations hidden in their datasets. Butler Scientifics is a privately held company headquartered in Barcelona, Spain. The founder, Ray G. Butler and his partner Luis García, each have over 10 years experience in Life Sciences. Ray G. Butler was formerly Software R&D Manager and then progressed into Product Development in terms of Marketing. Luis García has extensive Business Development and Sales Management experience. Software, Research, Exploratory Data Analysis, Life Sciences, Neurosciences, … Type: | 4 | 0 | 0 | 9 |
 |  Sunogel Inc Aiming at perfect skin regeneration MORE than 100 million patients develop scars from elective surgeries each year in developed countries alone.Sunogel is primarily directed toward the development of novel and regenerative therapeutics. At Sunogel, we investigate, incorporate and innovate functional three-dimensional scaffolds that can unlock the power of regeneration for damaged tissues, especially skin regeneration. Type: | 0 | 0 | 0 | 1 |
 | Vectalys By Flash Therapeutics | 0 | 0 | 0 | 3 |
 | Safic-Alcan A global independent specialty chemicals distributor Safic-Alcan is a French independent distributor of specialty chemicals headquartered in Paris La Défense (France). The Company develops and provides wide ranges of polymers, materials and additives for the rubber, coatings, adhesives, thermoplastics, polyurethane, lubricants, detergency, cosmetics, pharmaceuticals and nutraceuticals industries. With a network of 34 offices strategically located in Europe, Turkey, the Middle East, China, the USA, Brazil, Canada and Mexico. The company represents state-of-the art manufacturers around the world. Its highly specialized sales engineers allow Safic-Alcan to provide dedicated technical expertise and high performance solutions thus creating long term partnership with most … Type: | 4 | 2 | 2 | 552 |
 | Myogenes Helping GPs and Psychiatrists choose the right medication for their patients. Psychiatric Testing | DNA Testing Helping GP's and Psychiatrists choose the right medication for their patients. Psychiatric Testing | DNA Testing | Cancer Testing | Pharmacogentic Testing genetic testing, pharmacogenomics, mental health, depression, anxiety, OCD, ADHD, bipolar disorder, PTSD, personalised medicine, autism, personalised healthcare, BRCA, hereditary cancer, cancer risk, genetics, DNA testing, psychiatric, healthcare, and medication Type: | 1 | 0 | 1 | 10 |
 | Panakeia Rapid, instrument-free precision cancer diagnostics Panakeia offers an AI platform to enable simplified, rapid diagnostics to inform the precision treatment of cancer Machine Learning, Deep Learning, Artificial Intelligence, Cancer Diagnostic, and Personalized Medicine Type: | 2 | 0 | 2 | 23 |
 | Sequential - The Skin Microbiome Testing CoTM The Skin Microbiome Testing Co.TM Sequential Skin and Sequential Bio fall under the umbrella of Sequential: The Skin Microbiome Testing CoTM Awarded the title "Most Significant" Testing Solution in the Industry - (Cosmetics & Toiletries, 2022), Sequential Bio is the skin microbiome company of the industry that specializes in microbiome testing and claims substantiation for brands formulating products for skin, scalp, vagina/vulva and oral care. Sequential offers a full end-to-end platform from study design, recruitment and clinical testing, to microbiome analysis, and support on formulation development and certification. (www.sequential.bio) Sequential Skin on the other hand is revolutionising skin health with … Type: | 0 | 0 | 0 | 17 |
 | Gradientech Precision medicine for a sustainable world. Gradientech is a Swedish in vitro diagnostics company that supports the modern microbiology lab with cutting-edge solutions to facilitate the workflow with time-critical samples. Our product, QuickMIC®, is an ultra-rapid system for antibiotic susceptibility testing (AST) of positive blood culture samples from sepsis patients. QuickMIC® is a scalable system with each instrument analysing one sample against a tailored gram-negative antibiotic panel. MIC values are reported in as short as 2 hours, making it more rapid than any other diagnostic system for phenotypic AST. Gradientech’s technology combines microfluidics with live imaging to analyse bacterial responses … Type: | 0 | 0 | 0 | 42 |
 | 199 Biotechnologies Combating disease and aging by reversing age-related cellular changes through epigenetic reprogramming. 199 Biotechnologies is an early-stage company developing first-in-class therapies that target the fundamental mechanisms of aging, with the goal of transforming the landscape of age-related disease treatment and prevention. | 0 | 0 | 0 | 10 |
 | Molecular Partners Pioneering DARPin Therapeutics for Patients Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA. DARPins, Oncology, Immuno-Oncology, Radiopharmaceuticals, … Type: | 0 | 0 | 0 | 175 |
 | Blue Earth Therapeutics Blue Earth Therapeutics Ltd is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat patients who have cancer. With proven leadership and therapeutic radiopharmaceutical expertise, Blue Earth Therapeutics has an emerging pipeline of precision targeted therapeutic radiopharmaceuticals, initially focused on prostate cancer with plans to expand into additional disease areas in oncology. The Blue Earth Therapeutics story begins in 2021, when the company was formed in Oxford, UK as a sister company to Blue Earth Diagnostics Ltd and part of the Bracco family of companies. Bracco Imaging S.p.A. is a world‐leading diagnostic imaging … Type: | 0 | 0 | 0 | 12 |
 | Axovia Therapeutics Driving gene therapy breakthroughs to develop transformative AAV treatments for patients with ciliopathies like BBS Axovia Therapeutics is dedicated to the research and development of novel AAV gene therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families and caregivers. Axovia is currently developing therapies for patients with mutations in the BBS1 gene which manifests as Bardet Biedl Syndrome. Our initial goal is to halt the progression of BBS by targeting the most debilitating aspects of the neurological, metabolic and retinal dysfunctions. Type: | 0 | 0 | 0 | 6 |
 | Novus Diagnostics Developing ground-breaking diagnostics technologies that provide rapid answers right at the patient’s bedside When a patient is critically ill, giving their doctor the right information at the right time can mean the difference between life and death. At Novus Diagnostics, we are developing ground-breaking diagnostics technologies to provide rapid answers right at the patient’s bedside. Our first product, SepTec, will help tackle the global challenge of sepsis which kills more than 11 million people every year. Our technology platform brings together novel electrochemical sensors, centrifugal microfluidics and automated sample processing and analysis to diagnose and characterise a blood stream infection … Type: | 0 | 0 | 0 | 20 |
 | Proteotype Diagnostics Detect. Predict. Monitor. We profile the fundamental building blocks of life, providing cross-sectional snapshots, like a CT scan for your blood. We want to impact both primary and secondary care pathways. Our mission is to light the way in which cancer is diagnosed, treated and monitored. We aspire to deploy at population-level within the UK and globally. Predictive Biomarkers, Companion Diagnostics, CoDx, Complementary Diagnostics, Cancer Early Detection, MCED, Immuno-Diagnostic, and Liquid Biopsy Type: | 0 | 0 | 0 | 8 |
 | Blue Cell Therapeutics We are dedicated to develop novel stem cell therapies to treat chronic diseases Welcome to Blue Cell Therapeutics' LinkedIn page! At Blue Cell Therapeutics, our mission is to revolutionize the treatment of erectile dysfunction applying Blue Cell therapy, for men with post-(radical) prostatectomy. We are committed to develop an 'off-the-shelf' curative allogenic stem cell therapy for erectile dysfunction with enhanced safety, efficiency, and accessibility. Our cutting-edge research translates fundamental science into practical, life-changing treatments, bridging the gap between scientific discovery and clinical application. Blue Cell Therapeutics aims to establish the golden standard treatment for erectile dysfunction using innovative stem cell … Type: | 0 | 0 | 0 | 13 |
 | AAX Biotech AB Leveraging science and innovation to accelerate the development of next-generation antibody therapeutics. AAX Biotech AB is a biotech company spun out from Karolinska Institutet by co-founders Mats AA Persson and Daniel X Johansson. We specialize in next-generation antibody therapeutics through our two unique and proprietary technologies, SeqitopeTM and Opti-mAbTM, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. Our team is made up of highly qualified experts, all with PhDs in relevant fields. Our mission is to innovate and solve unmet needs … Type: | 3 | 0 | 3 | 4 |
 | Fluicell Making tissue therapeutics possible to defeat serious disease Fluicell is transforming how we treat disease with one-of-a-kind tissue solutions for regenerative medicine and drug screening. With the groundbreaking Nexocyte platform, based on twenty years of disruptive and patent-protected R&D, we are creating new ways to target serious diseases using precision-engineered biological tissues. Our transplantable tissues have the potential to help patients living with uncurable tissue damage related to cardiac, pulmonary, metabolic, kidney and other diseases. Fluicell’s first ambitious goal is to develop transplantable tissues to cure type 1 diabetes, impacting the lives of millions of patients. Nexocyte-generated tissues also enable … Type: | 0 | 0 | 0 | 16 |
 | AviadoBio A revolution in gene therapy for neurodegenerative disorders. At AviadoBio, we are relentlessly chasing cures by translating groundbreaking science and precision delivery into life-changing medicines for people living with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). With our deep understanding of the brain and our suite of proprietary gene therapy platforms and delivery technologies, we are working relentlessly to overcome the challenges of delivering the right drug to the right place. Our innovative, neuroanatomy-led approach is designed to maximize the therapeutic potential of gene therapy to halt or potentially reverse neurodegenerative diseases. The Company’s technology is based on pioneering … Type: | 1 | 1 | 1 | 69 |
 | Resolution Therapeutics Pioneering Macrophage Cell Therapy for Transformative Outcomes in Inflammatory Organ Diseases Resolution Therapeutics is a biotechnology company developing macrophage cell therapy to treat inflammatory organ disease. The company was founded following a productive collaboration between Edinburgh’s Centre for Regenerative Medicine, the Scottish National Blood Transfusion Service, and Syncona Investment Management Limited. The company is based in the Centre for Regenerative Medicine on the Edinburgh Royal Infirmary Campus, and is backed by Syncona. Our initial focus is in chronic liver disease. It is the only chronic disease still on the rise in western countries, and affects millions of people worldwide. Unfortunately, … Type: | 2 | 0 | 2 | 80 |
 | ADNTRO GENETICS Love your DNA 🧬 Genetic progress in recent years is only comparable to the advancements in the field of computer science. Our vision is to enable everyone to learn about their unique genetic code and inspire new ideas and scientific approaches. Since the completion of the human genetic code in 2003, the number of studies and sources of information on genetic markers, along with the scientific drive to better understand the genotype-phenotype has grown exponentially. In ADNTRO we help you navigate all present & future findings. Invest in your DNA – its for Life. GWAS, Genetics, Education, bioinformatics, Polygenic risk … | 0 | 0 | 0 | 15 |
 | Dia Beta Labs Ltd Target-led management of the causes of metabolic disease Diabetes currently effects over 537 million adults worldwide, with obesity-driven Type 2 Diabetes accounting for over 90% of cases. Dia Beta Labs build on over 30 years of high-impact research from our founding research group at Ulster University to realise the potential of next-generation therapeutics for metabolic disease. It is our goal to impart significant and much-needed change in the management of the global diabetes/obesity crisis. Diabetes, Peptide Development, Metabolic Disease, Obesity, and Peptide Therapeutics Type: | 1 | 0 | 1 | 3 |
 | IXICO Experts in end-to-end management and analysis of neuroimaging clinical trials powered by expertise & AI. Advancing medicine and human health by transforming data into clinically meaningful insights. IXICO is a premier neuroimaging provider helping biopharmaceutical companies maximize the value of their drug development pipelines by transforming data into clinically meaningful insights. Bringing together world-class therapeutic expertise, breakthrough analytics and operational excellence, IXICO is the proven partner of choice for imaging biomarker solutions in CNS clinical trials. Medical imaging, Clinical Trials, Alzheimer's Disease, Clinical Decision Support, Parkinson's Disease, Multiple Sclerosis, Progressive Supranuclear Palsy, Huntington's Disease, Cerebrovascular Disease, Digital Biomarkers, Neuroimaging, AI-driven … Type: | 0 | 0 | 0 | 80 |
 | Shift Bioscience Simulation guided cell rejuvenation to defeat the diseases of aging Shift Bioscience is using simulation guided cell rejuvenation to defeat the diseases of aging. Cellular reprogramming with Yamanaka factors can reverse aging in the dish but is not yet safe for clinical use. Shift has pioneered the first high throughput and high accuracy aging biomarker, which has been leveraged inside AI-based cell simulations to identify safer rejuvenation gene-factors. Shift envisions the development of a single drug-family that can treat multiple diseases of aging, after which full and continued health into old age becomes the norm. longevity, reprogamming, machine learning, aging … Type: | 0 | 0 | 0 | 16 |
 | sallea Adding the third dimension to cells. The growth of cells of a living being is key for an increasing range of applications, including in-vitro drug testing and cellular agriculture. In order to closely mimic the natural environment of such cells in-vitro, highly porous structures with tuneable mechanical and permeability properties are required. Sallea is developing such scaffolds with highly controlled pore size, shape and overall porosity from a broad range of relevant materials. metamaterials, regenerative medicine, 3D cell cultures, 3D printing, life science, and cellular agriculture Type: | 2 | 2 | 0 | 8 |
 | clock.bio Extending and improving the quality of life by reversing the harmful effects of time in our cells Ageing is natural but not inevitable. Some cells never age. Imagine if we could decode their rejuvenation programme. Imagine if we could prevent the diseases caused by ageing cells. Imagine a future where health is our default state Type: | 0 | 0 | 0 | 11 |
 | 4Tissue Shaping the future of regenerative medicine 4Tissue is an innovation-led research and clinical development organization. Our mission is to redefine the boundaries of tissue reconstruction, regeneration, and anti-aging, utilizing innovative biocompatible and bioresorbable polymers platform The first product, a bioresorbable injectable hydrogel, is focused on a better cell survival and the full regeneration of adipose tissue for breast reconstruction and augmentation applications. Type: | 1 | 0 | 1 | 6 |
 | Purespring Therapeutics We are Purespring. We are on a mission to radically transform the treatment of kidney diseases. Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through AAV gene therapy. This approach is based on the work of Professor Moin Saleem, Professor of Paediatric Renal Medicine at the University of Bristol, where he heads a world leading group researching glomerular diseases. biotechnology, gene therapy, and kidney diseases Type: | 1 | 1 | 1 | 52 |
 | Mindpeak GmbH Our mission is to enable personalised cancer treatment through AI tissue diagnostics Mindpeak's mission is to enable personalised cancer treatment through AI tissue diagnostics Our partners are leading pathology and university labs. Our team consists of world-class industry experts in machine learning and company building. Mindpeak's Impact The demand for medical image analysis is growing rapidly but the number of cancer experts remains the same - this results in growing workloads per specialist. We help cancer experts meet this challenge. We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in … Type: | 1 | 0 | 1 | 29 |
 | Booster Therapeutics Pioneering proteasome therapeutics for a new approach to complex disease Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function. Type: | 0 | 0 | 0 | 7 |
 | LoQus23 Therapeutics Ltd Stopping DNA instability; Slowing neurodegenerative disease LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases. Type: | 1 | 0 | 1 | 10 |
 | MONCYTE Health Unique technology and novel data for personalized and optimal treatment of high cholesterol MONCYTE Health has a unique proprietary technology to quantify individual differences in cellular lipid uptake and storage which contribute to high blood cholesterol and the effectiveness of common lipid-lowering drugs. The readouts are derived from white blood cells, including monocytes, which play key roles in atherosclerotic plaque formation and inflammation, linking directly to cardiovascular risk. Precisely quantifying these individual differences enables personalized treatment strategies in combination with risk assessment which can help patients more effectively achieve optimal blood cholesterol levels faster, and thereby reduce the risk for … Type: | 0 | 0 | 0 | 3 |
 | Lexicon Pharmaceuticals, Inc. At Lexicon, We Pioneer Medicines that Transform Patients' Lives Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. The Genome: Our Source of Discovery We have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies … Type: | 0 | 0 | 0 | 420 |
 | SSRN Early stage research platform sharing tomorrow's research today. SSRN is an online repository of scholarly research. It was founded to provide an alternative distribution vehicle for scholarly research, enabling work to be shared as quickly and efficiently as possible at the lowest cost - in effect, providing Tomorrow's Research Today. SSRN began in 1994 as one finance network; today it spans more than 60 distinct networks in health, applied, physical, life, social sciences and the humanities. The eLibrary currently houses more than 800,000 full-text papers from more than 500,000 authors worldwide. Papers are being downloaded at an annual rate of … | 28 | 2 | 24 | 79 |
 | Huntsville/Madison County Chamber The Huntsville/Madison County Chamber serves as the catalyst for economic development activities in our community. The Huntsville/Madison County Chamber, located in Huntsville, Alabama, is an organization of businesses, professionals and local leaders working to ensure a secure and sustainable economic future for our community. The Chamber’s vision is to provide for an enhanced quality of life for all citizens in our region, and our mission is to prepare, develop, and promote the community for economic growth. Meeting our goals and objectives is made possible through the dedicated efforts of Chamber volunteers, community leaders, and a talented Chamber staff focused on … Type: | 8 | 0 | 7 | 66 |
 | STAEDEAN Life Sciences We empower companies with our purposeful, intelligent solutions. Last mile solutions to peak your business performance. At STAEDEAN, we are dedicated to transforming business operations through our innovative ERP solutions embedded within the Microsoft ecosystem. Specializing in the rental, life sciences, and manufacturing industries, we deliver functionality to meet specific industry needs and resolve complex challenges. Additionally, our data solutions, designed to enhance integration, migration, governance, security, and analytics, serve as a solid foundation for organizations across various sectors. By partnering with us, companies gain access to intelligent, transformative solutions that drive efficiency, compliance, and growth, ensuring operational excellence and … | 1 | 0 | 1 | 219 |
 | Bioiberica We are a global life science company committed to improving the health and well-being of people, animals and plants. As a global life science company, taking care of human, animal and plant life has been our priority for over 45 years. Today, we are a world leader in the production of heparin – the primary anticoagulant used to save approximately 100 million lives every year. We have also set the benchmark for the manufacture of APIs and functional ingredients for the pharmaceutical, nutraceutical, veterinary, animal nutrition and agricultural sectors. We work to innovate in human, animal, and plant health. Discover … | 2 | 0 | 1 | 308 |
 | Iodysséus [Automatic translation follows] Marine environment awareness program, plankton. Ocean data & models. The Iodysséus program is supported by the Science&Sea Endowment Fund. They are invisible to the naked eye but regulate our climate and help make our planet breathable. They impact our daily lives, our health, our economies... "They" are myriads of particles and micro-organisms suspended in aerosols above the Ocean. Their interactions, between the atmosphere and the surface, in the global climate machinery is not unknown. But we are unable to parameterize them. The losses induced by disruptions of which they are vectors amount to hundreds of billions of … Type: | 6 | 2 | 5 | 3 |
 | GIPTIS (Genetics Institute for Patients, Therapies, Innovation & Science) The majority of rare diseases are chronic disorders which are most often of genetic origin (in 80% of the cases) and mainly affect children (60%). Each disease is rare (1/2000 person), but together the rare disorders affect around 6-8% of the general population. The number of people suffering from rare diseases is estimated to be around 3 million in France, 50 million in the Mediterranean Basin, 25 to 30 million in Europe and 27 million in North America. But Less than 5 % of patients receive an adapted treatment! A new healthcare model > GIPTIS (Genetics Institute for Patients, Therapies, … Type: | 3 | 2 | 3 | 1 |
 | IntegraGen IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present … Type: | 6 | 4 | 2 | 55 |
 | CRF Assurances - A howden company Le plus grand risque, c'est de penser que vous ne risquez rien. Created in 1999, CRF Assurances is a French Insurance Broker, specialized in Financial Lines risks. CRF Assurances is offering a large scale of insurance products which are customized and tailored made to suit profiles and activities for : - Startup from seed-stage to IPO quotation (Digital, Life Science and E-Health) - Financial Institutions (VC, Asset Management, Fintech) - Incubators CRF Assurances is notably specialized in General Liability, Professional Liability, E&O, D&O, Cyber, EPL and Property damages Fusions & Acquisitions, Responsabilité des Dirigeants, Homme-clé, Responsabilité Professionnelle, Kidnapping, Fraude, CyberRisques, … Type: | 53 | 6 | 56 | 25 |
 | Fondation Neurodis [Automatic translation follows] Together, let's help research into brain diseases! The Neurodis Foundation supports a network of 800 researchers and clinicians in Rhône-Alpes & Auvergne to develop basic and clinical research projects on the brain. The goal is to provide new research solutions in neuroscience, so that patients and their loved ones benefit as quickly as possible from medical advances on the brain. Type: | 13 | 1 | 12 | 4 |
 | Fondation ARC pour la recherche sur le cancer [Automatic translation follows] Our conviction: research will defeat cancer. Our goal: to cure cancer, all cancers! The teams at the ARC Foundation share a common conviction: only research will defeat cancer! This is why we have placed research at the heart of our mission, research on cancer and for individuals, dynamic and positive research, accessible to the greatest number. Even if the challenges remain numerous... We act every day to unleash the potential of French cancer research: • by drawing up its strategic orientations, • by supporting the most innovative initiatives of today for tomorrow, • by accelerating the most … Type: | 26 | 5 | 15 | 78 |
 | Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: | 13 | 10 | 4 | 8 |
 |  Institut de Psychiatrie et Neurosciences de Paris [Automatic translation follows] IPNP studies neuroscience and psychiatry, to understand the biological mechanisms and to offer new cares and treatments The Institute of Psychiatry and Neurosciences of Paris (IPNP) is a multi-disciplinary community of ~200 basic researchers, clinical neuroscientists and faculty members working on: neurodevelopment and psychiatry, behavior, memory and emotions, neurovascular systems, multiscale imaging (from molecules to whole brain), translational neurosciences, and molecular and cellular mechanisms in healthy and diseased brains. IPNP also provides core facilities and services to ensure that the teams have access to the most advanced technologies allowing the development of modern psychiatric and neuroscience research … Type: | 2 | 0 | 0 | 39 |
 | NovaGray Personalizing Cancer Treatment with Predictive Radiotherapy Tests Personalizing Cancer Treatment with Predictive Radiotherapy Tests. At NovaGray, we are committed to transforming the way breast and prostate cancer patients experience radiotherapy by personalizing treatment and minimizing risks. We are a pioneering French company, spin-off from the leading cancer ICM based in Montpellier, specializing in the development of the first-ever predictive tests for radiotherapy tolerance. These tests, designed for breast and prostate cancer patients, are a major step forward in precision medicine. How It Works: Before beginning radiotherapy, with just a simple blood test 🩸, NovaGray assesses a patient’s unique radiosensitivity. This … Type: | 5 | 1 | 4 | 6 |
 | EURORDIS-Rare Diseases Europe Working across borders and diseases to improve the lives of all people living with rare diseases. EURORDIS-Rare Diseases Europe is a unique, non-profit alliance of over 1,000 rare disease patient organisations from more than 70 countries that work together to improve the lives of all people living with rare diseases in Europe. By connecting and mobilising all stakeholders from within and outside the rare disease community, EURORDIS strengthens the voice of people living with rare diseases and shapes research, policies and services. Our vision is a world where all people living with a rare disease can have longer and better … Type: | 24 | 5 | 14 | 97 |
 | Dynamic42 GmbH Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies Type: | 1 | 0 | 1 | 23 |
 |  Qureight Data curation to accelerate drug development Qureight is a clinical data analytics company based in Cambridge UK. Working with healthcare institutions, technology companies and the pharmaceutical industry our platform allows the realisation of new endpoints in clinical data. Type: | 8 | 0 | 8 | 30 |
 | Occuity Occuity is developing novel optical monitoring & diagnostic devices. Occuity's mission is to improve the lives of hundreds of millions of people by developing painless, contact-free screening & monitoring solutions for health conditions such as #diabetes, #myopia, #glaucoma and #Alzheimer's Disease. Occuity is a UK-based medical technology company specialising in the research, design, and production of handheld non-contacting optical instruments for use in healthcare, diagnostics, and monitoring. Occuity’s scanning technology uses light to obtain precise measurements of different structures within the eye. This will enable direct measurements of the eye for optometrists and ophthalmologists but also other more general health … Type: | 3 | 0 | 3 | 38 |
 | Cytochroma Accelerating global drug development Cytochroma predict how drugs will react in a global population in health or disease. Our unique, ethnically diverse library of iPSC and automated cell culture generates robust, reliable, mature hepatocytes for toxicity testing. We are supporting life science companies, de-risking safe compounds prior to clinical testing, making new drug development faster, safer and more efficient. toxicity testing, liver specialists, hepatocyte testing, disease models, high throughput, high content screening, iPSC, automated manufacture, machine learning, artificial intelligence, predictive testing, and pre clinical testing Type: | 2 | 0 | 3 | 2 |
 | Causaly Causaly accelerates how humans acquire knowledge and develop insights in Biomedicine. Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies. Artificial Intelligence, Natural Language Understanding, Knowledge graphs, Pharma, and Life Sciences Type: | 6 | 0 | 4 | 122 |
 | CRISPR Therapeutics CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., … Type: | 12 | 5 | 5 | 442 |
 | BIOTECAL [Automatic translation follows] Biotecal is a biotechnology company that researches, develops and valorizes innovative marine biomolecules. Biotecal's unique expertise and know-how enable the identification, characterization and marketing of molecules with very high potential for various sectors such as cosmetics, pharmaceuticals or nutraceuticals. blue biotechnology, microbiology, biodiversity, and polymer production Type: | 0 | 0 | 0 | 3 |
 | BIOS Health Ltd Code the body can run. BIOS Health uses AI-driven insights from the nervous system to build neural digital therapies - the next big trend in precision medicines. The human nervous system carries vast quantities of data, and BIOS’ ability to precisely link nerve activity to specific conditions through the discovery of their neural biomarkers is a game changer for precision medicine. BIOS’ research could hold the key to new treatments for conditions including hypertension, diabetes, rheumatoid arthritis, and even diseases of the brain itself such as Parkinson’s or Alzheimer’s. BIOS is positioned to provide the neural code on which a … Type: | 26 | 8 | 22 | 28 |
 | BioCoS #DNAauthenticity #Biotech #EVOO #DNATraceability #Bioinformatics #Health #Biomarkers BioCoS's primary endeavor is to deliver innovative and bespoke solutions for the DNA traceability and authentication of raw materials throughout the supply chain in the realms of food and pharmaceuticals/cosmetics. Through strategic partnerships and continuous research, BioCoS remains at the forefront of transforming traceability practices, paving the way for a more secure and sustainable future in both industries. Bioinformatics, Computational Science, Biotechnology, Biostatistics, Genomics, Transcriptomics, Databases, Image analysis, Health Systems, DNA tag, DNA traceability, DNA authenticity, Molecular tags, food authenticity, and food safety Type: | 3 | 0 | 3 | 6 |
 | BenevolentAI Accelerate scientific breakthroughs and transform R&D outcomes BenevolentAI is a pioneer and leader in applying advanced explainable AI to drug discovery and development. In a world where the drug development failure rate still exceeds 90% and thousands of complex diseases lack effective treatment, our technology can increase the probability of success and reduce timelines. Our proprietary Benevolent PlatformTM is one of the industry’s most established and validated AI drug discovery technologies. In 2020, it took our scientists just 48 hours to identify baricitinib as a potential treatment for COVID-19. This became the first AI-identified drug indication to receive full FDA … Type: | 33 | 8 | 14 | 228 |
 | AYOXXA Biosystems GmbH AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics … Type: | 2 | 2 | 1 | 23 |
 | alpha.one Predict consumer behaviour. Our predictive AI models provide smart insights for clever marketers and designers. So you can focus less on opinions, and more on better content. Eye tracking, Machine learning, Neuromarketing, Neuroscience, TVC testing, Ad testing, Packaging design testing, Retail Insights, Entertainment Engagement, AI (Artificial Intelligence), AI, Pre-testing, and YouTube Type: | 12 | 0 | 7 | 29 |
 | Micron Agritech Driving sustainability in agriculture, one data point at a time. Welcome to Micron Agritech, where we're revolutionising the future of animal health. Our innovative platform equips the agriculture industry with advanced tools to analyse, track, and safeguard livestock and equine health with unparalleled precision—all from a convenient mobile interface. From identifying infections to proactive health management, our cutting-edge analysis tools empower vets and animal owners to ensure the well-being of their animals while driving sustainability in agriculture. Join us as we lead the charge towards a healthier, more resilient future for animals, one data point at a time. Follow our … Type: | 5 | 2 | 3 | 15 |
 | SomaDetect Providing farmers with the information they need to make the best possible milk. SomaDetect is an agricultural technology company that is connecting dairy farmers with the milk-quality indicators most relevant for the management of their production. Our optical technology allows for in-line measurements of critical dairy-quality indicators (fat content and somatic cells) from individual cows at every milking, enabling dairy farmers to identify problems early and produce the best possible milk. Computer Vision, Biotechnology, Deep Learning, Agrotechnology, AgTech, StartUp, Dairy, Data, Agriculture, Farming, and Food Type: | 4 | 1 | 0 | 18 |
 | Axithra Rapid Therapeutic Drug Monitoring Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time. The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments. Type: | 0 | 0 | 0 | 11 |
 | ImmuneBridge Amplifying nature’s innate intelligence to fight cancer ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consistent and abundant cellular source for immunotherapies. We are currently pursuing natural killer cell products for hematological malignancies. Next we will use the unique advantages of our cellular source to tackle solid tumors. Platform ImmuneBridge is creating a platform of scalable allogeneic immune cell therapies from cord blood. Our proprietary technology, including a novel small molecule, expands cord blood HSPCs over 100,000-fold while maintaining full immune multipotency, with … Type: | 0 | 0 | 0 | 26 |
 | Mendelian At Mendelian, rare diseases are our priority. We're enabling doctors to help patients earlier by finding the undiagnosed At Mendelian, our mission is to make rare diseases our priority. We have an amazing team who have built software, which enables doctors to help patients earlier, by finding the undiagnosed. Did you know that rare diseases are not actually rare? More rare diseases are life-threatening condition that are collectively common. In fact, 1 in 17 of us will be affected by a rare disease in our lifetime. This is comparable to common diseases such as diabetes and asthma. Rare disease symptoms … Type: | 9 | 1 | 7 | 22 |
 | Lucent Bio Healthy food starts with healthy soil. Lucent Bio is on a mission to accelerate the transition to a sustainable agri-food system through innovative crop input solutions that are climate-positive, non-polluting, and based on circular economy principles. Our products; Soileos, a micronutrient fertilizer, Nutreos, a microplastic-free seed coating; and Agreos, a microplastic-free controlled release fertilizer coating, harness the power of nature to deliver climate-positive results to Agri-food systems. Type: | 1 | 1 | 1 | 33 |
 | Plant Response A Mosaic Company. Developing soil health solutions and advancing crop nutrition to help grow the food the world needs. A Mosaic company. Our diverse portfolio of products is backed by science and used worldwide to enhance yields, improve nutrient use efficiency, disease defense, biocontrol and abiotic stress. We’re committed to developing new soil health solutions that will provide advanced crop nutrition to customers around the globe and continue to help the world grow the food it needs. Biostimulants, Plant Innate Immunity, Innovative solutions, Field trials, Crop production, Traits, Agrobiologicals, Sustainable agriculture, Biotic stress, and Abiotic stress | 1 | 0 | 1 | 10 |
 | genedrive Advancing Diagnostics to the Point Of Care genedrive plc is a molecular diagnostics company developing and commercialising a low-cost, rapid, versatile, simple to use and robust point of need molecular platform for use in patient stratification (genotyping). We are passionate about the opportunity to build a sustainable business around molecular diagnostics and to play an important role in the diagnostic and treatment challenges presented by global health issues. The company launched the Genedrive MT-RNR1 ID Kit, a pharmacogenetic test to prevent antibiotic induced deafness in infants, which was co-developed with the partners in the UK's National Health Service and is … Type: | 3 | 1 | 1 | 48 |
 | Dodie [Automatic translation follows] Mission-driven company 🌍 French brand of small childcare products for over 60 years. Dodie is THE essential French brand of childcare products. With over 60 years of expertise, it now meets all the needs of parents and babies with solutions that are both simple and innovative. The only cross-functional brand in the small childcare market in pharmacies and digital, Dodie is present in the baby bottles, pacifiers, hygiene products, care products and breastfeeding products section. Caring, sincere and reassuring, Dodie has always adapted to the needs of babies and the requirements of their parents. Since the first … | 0 | 0 | 0 | 10 |
 | NEOVACS Nous développons les thérapies de demain et investissons dans des sociétés innovantes en Biotech et Medtech Neovacs, a French Biotechnology company, develops therapeutic vaccines for the treatment of autoimmune, inflammatory diseases aand invests in innovative companies (Biotech and Medtech). active immunotherapies and therapeutic vaccine Type: | 2 | 0 | 1 | 21 |
 | Centre MEARY AP-HP [Automatic translation follows] AP-HP MEARY Center for Cellular and Genetic Therapy Installed in a building dedicated to research at the AP-HP Saint-Louis hospital, the AP-HP MEARY Center for Cellular and Genetic Therapy is dedicated to the production and distribution of experimental innovative therapy drugs (ITDs) for serious, chronic or rare diseases, such as leukemia, heart failure, and eye burns. These drugs, which represent tremendous hope for patients, are alternatives to so-called conventional treatments. | 3 | 1 | 1 | 10 |
 | AXEME Récoltez le talent, cultivez l'innovation ! Founded in 2004, Axeme is a recruitment agency specialized in the field of Life Sciences, Medical Devices, In Vitro Diagnostics and Biotechnologies. We recruit specific profiles from the development of a product or solution to the marketing phase including highly scientific and technical profiles. Research and development, quality, regulatory affairs, clinical, field specialist, business, marketing profiles to c-level positions in France and worldwide. We share our knowledge and force with startups, medium-sized and major companies in medical device to structure their organization. Christine Horvais, the founder, has set up a European network of consultants … Type: | 12 | 1 | 6 | 11 |
 | European Microbiome Innovation for Health Leading the way in Europe to bring microbiome-based innovations to market The Alliance Promotion Microbiote is becoming the European Microbiome Innovation for Health: a major step towards structuring the European microbiome excellence sector. European Microbiome Innovation for Health (EMIH) brings together innovative leading European stakeholders dedicated to advancing the microbiome industry. EMIH gathers more than 20 key players from public and private sectors: Bioaster, Biocodex, Biofortis, Biose Industrie, Cynbiome, Eligo Bioscience, Pelican Health, GMT, INRAE, Ferring Pharmaceuticals, Lallemand, Luxia, Lyonbiopole Auvergne-Rhône-Alpes, MaaT Pharma, Medicen, Microbiome Fundation, Nexbiome, Novobiome, PolePharma, Seventure Partners, Skyepharma supporting each other’s efforts to develop tomorrow’s medicine … Type: | 7 | 2 | 7 | 3 |
 | Ziwig Biotech Innovating for women's health Ziwig ® is a French company whose ambition is to improve women’s health through a holistic approach and the development of products, services and a care ecosystem guided by science and the unique biology of each individual. This approach is supported by ongoing research excellence and is based on the close collaboration of medical experts and engineers specialized in cutting- edge technologies such as artificial intelligence and Next Generation human RNA Sequencing. Its functioning is based on an ecosystem, driven by the quest for excellence and patient centered, that uses disruptive technologies. This contributes to the … Type: | 21 | 8 | 13 | 56 |
 | SynapCell We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such … Type: | 11 | 5 | 7 | 41 |
 | EMBRC - European Marine Biological Resource Centre We advance knowledge on marine biodiversity and ecosystems to foster sustainable initiatives. EMBRC a research infrastructure that accelerates marine biology and ecology research in Europe. Through a network of 80 marine sites across Europe, we provide access to marine biodiversity and ecosystems, services and expertise, to help researchers from academia and industry study the ocean's biodiversity and ecosystems to speed up discoveries and develop innovative solutions to societal issues. EMBRC fills gaps in ocean observation data through EMO BON (European Marine Omics Biodiversity Observation Network), the first coordinated long-term genomic biodiversity observatory in Europe that studies marine life using DNA … Type: | 20 | 3 | 18 | 20 |
 | Fluofarma Scientist-to-Scientist Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED … Type: | 0 | 0 | 0 | 2 |
 | Eurobio Scientific [Automatic translation follows] The Eurobio Scientific group is an integrated French player in in vitro diagnostics. Today, leader in the French in vitro diagnostics market, the Eurobio Scientific group continues its development by intervening from research to the marketing of specialty diagnostic products and products in the field of life sciences. Eurobio Scientific's know-how is based on the marketing of specialty diagnostic tests to hospital and private medical biology analysis laboratories. The group is also recognized in France as the market leader in HLA tests for transplantation. Eurobio Scientific also exclusively markets tests and automated solutions designed by our foreign … | 6 | 2 | 4 | 175 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 10 | 5 | 5 | 190 |
 | Vect-Horus Enhancing the transport of therapeutic and imaging agents using versatile and flexible targeting technologies VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based … Type: | 24 | 6 | 10 | 46 |
 | Cydan | 2 | 0 | 1 | 4 |
 | OM Pharma Transforming Immune Health We use our expertise in bacterial lysates to address the world’s most significant health challenges from the rise in infectious disease outbreaks to antimicrobial resistance. Currently active in the prevention of respiratory and urinary tract infections, our constantly evolving understanding of how bacterial lysates interact with the immune system motivates us to invest in new indications and new formulations for our lysates. Headquartered in Geneva with affiliates in Peru and Switzerland, our products are available in more than 100 countries through a network of trusted partners. Infectious diseases, Vascular diseases, and immunological imbalances Type: | 1 | 1 | 0 | 553 |
 | Lycored Cultivating wellnessTM Nutrition isn’t complicated. For us, it’s natural. We’ve been a leader in the research and development of carotenoid-based products for the last two decades and we take that role very seriously. This means we approach everything we do with a sense of wonder and a driving desire to find the best possible outcome or create the highest-quality product. Sometimes we begin with an actual seed (from one of our tomato farms) and sometimes we start with the seed of an idea—maybe a health-related concern or even a question that was posed by one of our scientists on a … Type: | 0 | 0 | 0 | 166 |
 | IMIBIC Maimonides Biomedical Research Institute of Cordoba The Maimonides Biomedical Research Institute of Cordoba – IMIBIC, is a joint Institute of the University of Cordoba (UCO), the Reina Sofia University Hospital, and the Junta de Andalucía Regional government, created in 2008. It is structured in research groups commissioned by these institutions that cooperate in the implementation of the five scientific programmes, including Active aging and Fragility; Nutrition and endocrine and metabolic diseases; Infectious and immunological diseases and organ transplants; Cancer (Oncology and Oncohematology); and Chronic and Inflammatory Diseases. IMIBIC brings together scientific research and medical practice to embrace integral projects with … Type: | 2 | 0 | 1 | 273 |
 | HELLO NATURE® Every day, for 50 years, we have grown our ideal of a sustainable future. Every day, HELLO NATURE! HELLO NATURE! Quality, passion and innovation have always been our leading values. Operating today in more than 70 countries worldwide, with 4 production sites and many commercial offices, HELLO NATURE® offers a wide range of organic fertilizers, biostimulants of vegetal origin, beneficial microbials certified all over the world. Every dawning day HELLO NATURE® is at farmers side, with hands in the earth, heart in the fruit, head in science. Every day, since fifty years, we search for innovative solutions to grow our … Type: | 3 | 2 | 1 | 102 |
 | 23andMe 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers … Type: | 27 | 7 | 6 | 866 |
 | Asuragen, a Bio-Techne brand People Deserve Better Answers Asuragen, a Bio-Techne brand, is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. Bio-Techne a global life sciences company providing innovative tools and bioactive … | 3 | 1 | 1 | 124 |
 | Palobiofarma S.L. Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors. Type: | 1 | 1 | 0 | 19 |
 | CO2 Solutions Inc. | 3 | 1 | 0 | N/A |
 | Proco Group International Executive Search and Advisory Partner | Commodity, Industrial and Consumer Markets Proco Group – Perfectly placed to help you navigate complexity. We are an executive search and advisory partner for organisations and senior professionals who are navigating the complexities of operating within and across the commodity, industrial and consumer markets. Our focus on industries, regions and professions across major value chains, means we’re perfectly placed to help you make insight-driven strategic decisions, create new possibilities and secure hard to find individuals. With the right people, anything is possible. To continue growing the network and knowledge that make us a … Type: | 6 | 0 | 7 | 67 |
 | Institute for Bioengineering of Catalonia (IBEC) International CERCA research centre focused on the present and future of Bioengineering Solutions for Health. The Institute for Bioengineering of Catalonia (IBEC) conducts excellent interdisciplinary research at the frontiers of engineering and life sciences in order to generate new knowledge by putting together fields like nanomedicine, biophysics, biotechnology, tissue engineering and the applications of health information technology. IBEC was established in 2005 by the Ministries of Innovation, Universities and Enterprises and Health of the Generalitat de Catalunya (Autonomous Government of Catalonia), the University of Barcelona (UB) and the Technical University of Catalonia (UPC). Today, IBEC’s relationship with the UB and … Type: | 9 | 3 | 5 | 316 |
 | IVCC (Innovative Vector Control Consortium) Saving lives, protecting health and increasing prosperity in areas where disease transmitted by insects is endemic. IVCC is the only Product Development Partnership (PDP) working in vector control. IVCC was established in 2005, through a $50 million grant to the Liverpool School of Tropical Medicine (LSTM) from the Bill & Melinda Gates Foundation, and is a registered charity in the UK. We work with stakeholders to facilitate the development of novel and improved public health insecticides and formulations to combat the rapidly growing problem of insecticide resistance. We bring together partners from industry, the public sector and academia to create … | 6 | 1 | 5 | 43 |
 | Pfizer Italia [Automatic translation follows] For more than 160 years, we have been working together for a healthier world. | 2 | 1 | 0 | N/A |
 | DCAT (Drug, Chemical & Associated Technologies Association) The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into … Type: | 11 | 1 | 11 | 36 |
 | LAUS Group Small enough to care and big enough to deliver LAUS is today an internationally recognized GLP certified testing facility (CRO) working in five areas of expertise: Analytical Chemistry, Physico-Chemistry, in vitro–Toxicology, Ecotoxicology, and Environmental Fate. LAUS provides a strong portfolio of studies in all five areas for a great variety of products like chemicals, pesticides, biocides, medical devices, medicinal products for veterinary and human use, cosmetics, food additives, and novel food. These tests are crucial for 1. registration purposes (e.g. REACH, BPR), 2. classification (e.g. GHS, CLP, Water Hazard Classes), 3. application for labeling (e.g. Ecolabel), 4. assessment of potential … Type: | 0 | 0 | 0 | 75 |
 | GO Concept [Automatic translation follows] A Step Ahead Go Concept is a technological innovation consulting firm. Our ambition? To bring together high potentials who invent and optimize the world of tomorrow. Today, we are 380 enthusiasts and we support around a hundred partners on multi-sector projects with high added value in the industrial sector. We are present in Switzerland, France, Belgium, Spain and Canada. Why join the Go Concept adventure? -> The pleasure and opportunity to evolve in a proactive environment, alongside renowned clients and experienced employees, all actors in their careers. -> Honesty and a sense of teamwork: we are a … Type: | 3 | 0 | 2 | 192 |
 | Centre de Recherche des Cordeliers Basic and translational research on cancer, immunity, metabolism and chronic diseases, toward precision medicine. Basic and translational research on cancer, immunity, metabolism and chronic diseases, to make precision medicine a reality. | 8 | 4 | 5 | 97 |
 | LabCom RISCA [Automatic translation follows] Biostatistical solutions for health data analysis: Registry cohorts https://www.labcom-risca.com/plug-stat The SPHERE laboratory (methodS for Patients-centered outcomes and HEalth REsearch, University of Nantes) and the company IDBC-A2com are partners of the RISCA Joint Laboratory (Research in Computer Science and Statistics for Cohort Analysis) with the aim of continuing the development of Plug-Stat® software dedicated to the analysis and valorization of observational cohort data. Our objective ? Encourage better use of our medical data to better leverage cohort data. Today, due to lack of resources, time and/or skills, most studies are based on the same statistical models, even though … Type: | 4 | 0 | 4 | 1 |
 | traceless materials materials designed for nature We are a circular bioeconomy startup, and we offer a novel biomaterial solution to tackle plastic pollution: traceless® materials! Being based on plant residues of the agricultural industry, our materials are fully biobased, plastic-free and home compostable. Our patent-pending technology to produce them is scalable, environmentally friendly and efficient: A science-based life-cycle assessment shows that compared to conventional plastics traceless® saves 91% carbon emissions and 89% fossil energy demand in production and disposal, all while preserving agricultural land and water resources, and completely avoiding the use of hazardous chemicals or additives. Founded in 2020 by Anne … Type: | 16 | 3 | 14 | 56 |
 | LPIXEL Inc. NEW VALUES FROM LIFE'S DISCOVERIES LPixel, a spin-out venture from the University of Tokyo, is a leader in advanced image analysis software and systems tailored to life science research. With strong emphasis on integrating top-tier technologies to its services and strong dedication to maximize research efficiency, LPixel aims to bring innnovation to the world of research. LPixel was founded in March 2014 by three members working in the same research laboratory in the University of Tokyo. Since the establishment of the laboratory in 2000, LPixel has continued to lead image analysis technology in the biological sciences. LPixel is involved in … Type: | 1 | 0 | 0 | 31 |
 | Motognosis We develop motion assessment systems for recognizing and analyzing motor dysfunction in people with neurologic diseases. Establishing clinical-grade tracking of motor symptoms using consumer sensors, we aim to open up new possibilities in research, routine diagnostics and therapy. Motognosis was founded in 2014 as a technology transfer startup from the Charité Neurodiagnostics Laboratory, NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin. Our dynamic team consists of 3D video analysis experts with different, complementary backgrounds, and works in close collaboration with experienced clinicians and clinical scientists. Imprint: Motognosis GmbH Schönhauser Allee 177 10119 Berlin Germany Managing Director: Sebastian Mansow-Model Email: contact@motognosis.com … Type: | 3 | 0 | 3 | 3 |
Startup